In vitro efficacy of ribavirin against canine distemper virus

Antiviral Research

Volumn 77, Issue 2, 2008, Pages 108-113

  Elia, Gabriella ^a   Belloli, Chiara ^a   Cirone, Francesco ^a   Lucente, Maria Stella ^a   Caruso, Marta ^a   Martella, Vito ^a   Decaro, Nicola ^a   Buonavoglia, Canio ^a   Ormas, Paolo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Antivirals; Canine distemper virus; Real time RT PCR; Ribavirin; VERO cells

Indexed keywords

RIBAVIRIN; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CANINE DISTEMPER MORBILLIVIRUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; IC 50; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERO CELL; VIRUS INHIBITION; VIRUS LOAD;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; DISTEMPER VIRUS, CANINE; DOGS; INHIBITORY CONCENTRATION 50; POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, VIRAL; VERO CELLS; VIRUS REPLICATION;

CANINE DISTEMPER VIRUS; CANIS FAMILIARIS; MEASLES VIRUS; MORBILLIVIRUS;

EID: 38149104763     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2007.09.004     Document Type: Article

References (34)

1. Adams J.M., and Imagawa D.T. Immunological relationship between measles and distemper viruses. Proc. Soc. Exp. Biol. Med. 96 (1957) 240-244
2. Appel M.J. In: Appel M.J. (Ed). Virus Infection of Carnivores (1987), Elsevier, Amsterdam 133-159
3. Appel M.J., and Gillespie J.H. Canine distemper virus. Virol. Monogr. 11 (1972) 1-96
4. Appel M.J., and Summers B.A. Pathogenicity of morbilliviruses for terrestrial carnivores. Vet. Microbiol. 44 (1995) 187-191
5. Baker R.O., Bray M., and Huggins J.W. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 57 (2003) 13-23
6. Borenfreund E., and Puerner J.A. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 24 (1985) 119-124
7. Bougie I., and Bisaillon M. The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme. J. Biol. Chem. 279 (2004) 22124-22130
8. Cinatl J., Michaelis M., Hoever G., Preiser W., and Doerr H.W. Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Res. 66 (2005) 81-97
9. Contreras A.M., Hiasa Y., He W., Terella A., Schmidt E.V., and Chung R.T. Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J. Virol. 76 (2002) 8505-8517
10. Cooper A.C., Banasiak N.C., and Allen P.J. Management and prevention strategies for respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a review of evidence-based practice interventions. Pediatr. Nurs. 29 (2003) 452-456
11. Crotty S., Maag D., Arnold J.J., Zhong W., Lau J.Y., Hong Z., Andino R., and Cameron C.E. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat. Med. 6 (2000) 1375-1379
12. Day C.W., Smee D.F., Julander J.G., Yamshchikov V.F., Sdiwell R.W., and Morrey J.D. Error-prone replication of West Nile virus caused by ribavirin. Antiviral Res. 67 (2005) 38-45
13. Elia G., Decaro N., Martella V., Cirone F., Lucente M.S., Lorusso E., Di Trani L., and Buonavoglia C. Detection of canine distemper virus in dogs by real-time RT-PCR. J. Virol. Methods 136 (2006) 171-176
14. Eriksson B., Helgstrand E., Johansson N.G., Larsson A., Misiorny A., Noren J.O., Philipson L., Stenberg K., Stening G., Stridh S., and Oberg B. Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob. Agents Chemother. 11 (1977) 946-951
15. Fontanges T., Beorchia S., Douvin C., Delassalle P., Combis J.M., Hanslik B., Jacques J.P., Filoche B., Desmorat H., Chandelier C., and Ouzan D. Safety and efficacy of combination therapy with peginterferon alfa-2a (40 kDa) and ribavirin in the outpatient setting: prospective analysis of 197 patients with chronic hepatitis C viral infection. Gastroenterol. Clin. Biol. 31 (2007) 566-572
16. Graci J.D., and Cameron C.E. Mechanisms of action of ribavirin against distinct viruses. Rev. Med. Virol. 16 (2006) 37-48
17. Grancher N., Venare V., Kedzierewicz F., Ammerlaan W., Finance C., Muller C.P., and Le Faou A. Improved antiviral activity in vitro of ribavirin against measle virus after complexation with cyclodextrins. Antiviral Res. 62 (2004) 135-137
18. Gururangan S., Stevens R.F., and Morris D.J. Ribavirin response in measles pneumonia. Infection 20 (1990) 219-221
19. Haas W.H., Breuer T., Pfaff G., Schmitz H., Köhler P., Asper M., Emmerich P., Drosten C., Gölnitz U., Fleischer K., and Günther S. Imported Lassa fever in Germany: surveillance and management of contact persons. Clin. Infect. Dis. 36 (2003) 1254-1258
20. Hong Z., and Cameron C.E. Pleiotropic mechanisms of ribavirin antiviral activities. Prog. Drug Res. 59 (2002) 41-69
21. Hosoya M., Shigeta S., Nakamura K., and De Clercq E. Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro. Antiviral Res. 12 (1989) 87-97
22. Kimura K., Mori S., Tomita K., Ohno K., Takahashi K., Shigeta S., and Terada M. Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo. Antiviral Res. 47 (2000) 41-141
23. Leyssen P., Balzarini J., De Clercq E., and Neyts J. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against Flaviviruses and Paramyxoviruses is mediated by inhibition of IMP dehydrogenase. J. Virol. 79 (2005) 1943-1947
24. Parker W.B. Metabolism and antiviral activity of ribavirin. Virus Res. 107 (2005) 165-171
25. Robins R.K., Revankar G.R., McKernan P.A., Murray B.K., Kirsi J.J., and North J.A. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin. Adv. Enzyme Regul. 24 (1985) 29-43
26. Schobesberger M., Summerfield A., Doherr M.G., Zurbriggen A., and Griot C. Canine distemper virus-induced depletion of uninfected lymphocytes is associated with apoptosis. Vet. Immunol. Immunopathol. 104 (2005) 33-44
27. Severson W.E., Schmaljohn C.S., Javadian A., and Jonsson C.B. Ribavirin causes error catastrophe during Hantaan virus replication. J. Virol. 77 (2003) 481-488
28. Shigeta S., Mhori S., Baba M., Ito M., Honzumi K., Nakamura K., Oshitani H., Numazaki Y., Matsuda A., Obara T., Shuto S., and de Clercq E. Antiviral activity of ribavirin, 5-ethynyl-1-β-d-ribofuranosilimidazole-4-carboxamide, and 6′-(R)-6′-C-methylneplanocin A against several ortho- and paramyxoviruses. Antimicrob. Agents Chemother. 36 (1992) 435-439
29. Sidwell R.W. Ribavirin: in vitro antiviral activity. In: Smith R.A., and Kirkpatrick W. (Eds). Ribavirin: A Broad Spectrum Antiviral Agent (1980), Academic Press Inc., New York 23-42
30. Smee D.F., Bray M., and Huggins J.W. Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro. Antiviral Chem. Chemother. 12 (2001) 327-335
31. Streeter D.G., Witkowski J.T., Gyaneshwar P.K., Sidwell R.W., Bauer R.J., Robins R.K., and Simon L.N. Mechanism of action of 1-β-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc. Natl. Acad. Sci. U.S.A. 70 (1973) 1174-1178
32. Wray S.K., Gilbert B.E., and Knight V. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. Antiviral Res. 5 (1985) 39-48
33. Wyde P., Moore-Poveda D.K., De Clercq E., Neyts J., Matsuda A., Minakawa N., Guzman E., and Gilbert B.E. Use of cotton rats to evaluate the efficacy of antivirals in treatment of measle virus infections. Antimicrob. Agents Chemother. 44 (2000) 1146-1152
34. Zhou S., Liu R., Baroudy B.M., Malcolm B.A., and Reyes G.R. The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA. Virology 310 (2003) 333-342